Clinical safety issues of measles, mumps and rubella vaccines

Bulletin of the World Health Organization

Volumn 78, Issue 2, 2000, Pages 199-204

  Afzal, M A ^a   Minor, P D ^a   Schild, G C ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Measles vaccine, adverse effects; Mumps vaccine, adverse effects; Rubella vaccine, adverse effects; Vaccines, attenuated, adverse effects and genetics

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; VIRUS RNA;

ARTICLE; AUTISM; CROHN DISEASE; DRUG RESEARCH; DRUG SAFETY; HUMAN; MEASLES VIRUS; MEDICAL LITERATURE; VIRUS DETECTION;

HUMANS; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; RUBELLA VACCINE; VACCINES, ATTENUATED; VACCINES, COMBINED;

EID: 0034060284     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Thompson NP et al. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet, 1995, 345: 1071-1074.
2. Wakefield AJ et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 1998, 351: 637-641.
3. Wakefield AJ, Montgomery SM, Pounder RE. Crohn's disease: the case for measles virus. Italian Journal of Gastroenterology and Hepatology, 1999, 31: 247-254.
4. Montgomery SM et al. Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology, 1999, 116: 796-803.
5. Ekbom A et al. Measles infection and subsequent Crohn's disease. Lancet, 1994, 344: 508-510.
6. Ekbom A et al. Crohn's disease after in utero measles virus exposure. Lancet, 1996, 348: 518-517.
7. Wood DJ, Macadam AJ. Laboratory tests for live attenuated poliovirus vaccines. Biologicals, 1997, 25: 3-15.
8. Rezapkin GV et al. Microevolution of Sabin 1 strain in vivo and genetic stability of oral poliovirus vaccine. Virology, 1994, 202: 370-378.
9. Hockin J, Furesz J. Mumps meningitis, possibly vaccine-related-Ontario. Canada Diseases Weekly Report, 1988, 14: 210.
10. Forsey T et al. Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxy nucleotice sequencing. Journal of General Virology, 1990, 71: 987-990.
11. Tookey PA, Peckham CS. Surveillance of congenital rubella in Great Britain, 1971-96. British Medical Journal, 1999, 318: 769-770.
12. Howson PC, Fineberg HV. Adverse events following pertussis and rubella vaccines. Journal of the American Medical Association, 1992, 267: 392-396
13. Slater PE. Chronic arthropathy after rubella vaccination in women Journal of the American Medical Association, 1997, 278: 594-595.
14. Ray P et al. Risk of chronic arthropathy among women after rubella vaccination. Journal of the American Medical Association, 1997, 278: 551-556.
15. Tingle AJ et al. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet, 1997, 349: 1277-1281.
16. Slater PE et al. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women. Vaccine, 1995, 13: 1529-1532
17. MMR vaccine coverage falls after adverse publicity. Communicable Disease Report Weekly, 30 January 1998, 8 (5).
18. MMR vaccine coverage falls in the United Kingdom. Communicable Disease Report Weekly. 29 January 1999, 9 (5).
19. Hermon-Taylor J et al. Measles virus and Crohn's disease. Lancet. 1995; 345: 922-923.
20. Miller E, Goldblatt D, Cutts F. Measles vaccination and inflammatory bowel disease. Lancet, 1998, 351: 755-756.
21. Taylor B et al. Autism and measles, mumps and rubella: no epidemiological evidence for a causal association. Lancet, 1999, 353: 2026-2029.
22. Wakefield AJ et al. Evidence of persistent measles virus infection in Crohn's disease. Journal of Medical Virology. 1993, 39: 345-353.
23. Wakefield AJ et al. In situ immune responses in Crohn's disease: A comparison with acute and persistent measles virus infection. Journal of Medical Virology, 1997, 51: 90-100.
24. ter Meulen V. Measles virus and Crohn's disease: view of a medical virologist. Gut, 1998, 93: 733-734.
25. Minor PD. Measles vaccination as a risk factor for inflammatory bowel disease. Lancet, 1995, 345: 1362-1363.
26. Iizuka M, Masamune O. Measles vaccination and inflammatory bowel disease. Lancet, 1997, 350: 1775.
27. Miyamoto H et al. [Studies for viral antigen in intestinal tissues from patients with Crohn's disease and ulcerative colitis.] Annual Report of the Research Committee of IBD, 1984: 50-53 (in Japanese).
28. Iizuka M et al. Absence of measles virus in Crohn's disease. Lancet, 1995, 345: 199.
29. Haga Y et al. Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut, 1996, 38: 211-215.
30. Afzal MA et al. Absence of measles-virus genome in inflammatory bowel disease. Lancet. 1998, 351: 646-647.
31. Afzal MA et al. Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes. Journal of Medical Virology, 1998, 55: 293-299.
32. Chadwick N et al. Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction. Journal of Medical Virology, 1998, 55: 305-311.
33. Afzal MA et al. Measles virus and Crohn's disease. Gut, 1999, 44: 896-897.
34. Feeney M et al. A case-control study of measles vaccination and inflammatory bowel disease. Lancet, 1997, 350: 765-766.
35. Peltola H et al. No evidence for measles, mumps and rubella vaccine-associated inflammatory bowel disease or autism in a 14-years prospective study. Lancet, 1998, 351: 1327-1328.
36. Armitage E et al. Incidence of juvenile-onset Crohn's disease in Scotland. Lancet, 1999, 353: 1496-1497.
37. Askling J et al. Incidence of paediatric Crohn's disease in Stockholm, Sweden. Lancet, 1999, 354: 1179.
38. Katayama Y et al. Detection of measles virus mRNA from autopsied human tissues. Journal of Clinical Microbiology, 1998, 36: 299-301.
39. Bitnun A et al. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clinical Infectious Diseases, 1999, 29: 855-861.